Odomzo (sonidegib) — Medica
Diffuse basal cell carcinoma formation (e.g., basal cell nevus syndrome [Gorlin syndrome] or other genetic forms of multiple basal cell carcinoma)
Initial criteria
- Patient is ≥ 18 years of age
Approval duration
1 year
Diffuse basal cell carcinoma formation (e.g., basal cell nevus syndrome [Gorlin syndrome] or other genetic forms of multiple basal cell carcinoma)
1 year